GGrantIndex
Sort

39,280 grants matching leukemia

The function of MS4A3 in normal and malignant hematopoiesis

$466,620
Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2023 · CA

miRNA Expression Profiling

$466,613
David M Brown · Ambion Diagnostics, Inc. · R44 · FY2007 · CA

Characterization and targeting of leukemia stem cell metabolism

$466,601
Craig T. Jordan · University Of Colorado Denver · R01 · FY2016 · CA

Selective HDAC6 inhibition deceases B cell activation in systemic lupus erythematosus

$466,545
Christopher Michael Reilly · Virginia Polytechnic Inst And St Univ · R15 · FY2020 · AI

Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines

$466,522
Stephen P Goff · Columbia University Health Sciences · R01 · FY2021 · CA

DNA Sequencing and Digital Gene Expression Core

$466,471
Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML

$466,344
Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Mechanisms of arsenical transport

$466,344
Barry P. Rosen · Florida International University · R37 · FY2011 · GM

Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML

$466,344
Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Coordinate Gene Regulation in Animal Cells

$466,287
John T Lis · Cornell University · R01 · FY2020 · GM

O2 sensing in the human and rabbit ductus arteriosus

$466,215
Stephen L Archer · University Of Chicago · R01 · FY2010 · HL

REGULATION OF NEUROENDOCRINE SWITCHING EVENTS

$466,208
University Of California San Diego · R37 · FY2002 · DK

Arsenic Trioxide in Primary Curative APL Therapy

$466,191
Johns Hopkins University · R01 · FY2005 · CA

Impact of tuberculosis on the development and function of the immune system in SIV-infected infants

$466,181
Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD

Therapy of PARP inhibitor-associated myeloid neoplasms in ovarian cancer patients

$466,152
Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2025 · CA

Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adults

$466,089
Sung Won Choi · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Gene Therapy Clinical Trials for Chronic Granulomatous Disease

$465,906
Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

MAPPING CHROMOSOMES AND GENES IN RELATION TO LEUKEMIA

$465,852
Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA

Targeting PML for Leukemia Therapy

$465,791
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2016 · CA

Targeting PML for Leukemia Therapy

$465,791
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA

HIV-1 Intasome Assembly and Function

$465,704
Kristine E Yoder · Ohio State University · R01 · FY2024 · AI

Coordinate Gene Regulation in Animal Cells

$465,677
John T Lis · Cornell University · R01 · FY2019 · GM

Training Program in Molecular Hematology

$465,675
William H Fleming · Oregon Health & Science University · T32 · FY2008 · HL

Queens Cancer Center Minority-Based Community Clincal Oncology Program

$465,669
Margaret Margaret Kemeny · Queens Hospital Center · U10 · FY2012 · CA

Queens Cancer Center Minority-Based Community Clincal Oncology Program

$465,669
Margaret Margaret Kemeny · Queens Hospital Center · U10 · FY2011 · CA